Product Information
BI-0252 is a small molecule with cellular and molecular targets that are involved in protein homeostasis. It has been shown to interact with the ubiquitin-proteasome system, a molecular machine that regulates protein turnover and degradation. BI-0252 has also been shown to inhibit the p53 protein and has potential as a therapeutic agent for cancer.
BI-0252 is orally bioavailable and displays good pharmacokinetic properties in rats, which could make it an attractive candidate for further development.
Chemical properties
Technical inquiry about: 3D-TXC29127 BI-0252
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.